Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Stephen Sabba Insider Profile

4 Followers

Stephen Sabba, Director at Ligand Pharma, holds 33.63K shares in Ligand Pharma (Ticker: LGND), holds 37.00K shares in Novelion Therapeutics (Ticker: NVLNF).

Stephen Sabba's Trading History

LGNDLigand Pharma		Jun 18, 2026DirectorUninformative Buy141.85K$10.85M
NVLNFNovelion Therapeutics		Jul 01, 2015―Informative Buy87.13K$25.97K
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Stephen Sabba insider profile FAQ

What is the percentage of profitable transactions made by Stephen Sabba?
The percentage of profitable transactions made by Stephen Sabba is 36%.
What is the average return per transaction made by Stephen Sabba?
The average return per transaction made by Stephen Sabba is -14.40%.
What stocks does Stephen Sabba hold?
Stephen Sabba holds: LGND, NVLNF stocks.
What was Stephen Sabba’s latest transaction?
Stephen Sabba’s latest transaction was an Uninformative Buy of $141.85K.
What was Stephen Sabba's most profitable transaction?
Stephen Sabba’s most profitable transaction was an Informative Sell of LGND stock on September 6, 2018. The return on the trade was 65.10%.
What is Stephen Sabba's role in Ligand Pharma?
Stephen Sabba's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.